ReviewHealthcare (Basel, Switzerland)2026
Algorithmic Prognostication in Female Oncofertility Counseling: Ethical Challenges of Bias, Autonomy, and Predictive Uncertainty.
Review in Healthcare (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Advances in machine learning, predictive analytics, and clinical prediction modeling have accelerated the development of algorithmic tools for estimating reproductive outcomes after cancer treatment. In female oncofertility counseling, these models may support individualized assessment of treatment-related amenorrhea, premature ovarian insufficiency, and fertility risk, thereby improving risk communication and timely fertility-preservation referral. However, their use raises ethical concerns beyond predictive accuracy. This narrative review examines algorithmic prognostication in female oncofertility counseling, focusing on predictive uncertainty, surrogate reproductive endpoints, missing data, heterogeneous datasets, limited external validation, algorithmic bias, reproductive inequity, and the influence of algorithmic authority on patient autonomy and shared decision-making. We argue that predictive algorithms should be understood as decision-support tools rather than determinants of reproductive futures. Responsible implementation requires transparency, explainability, fairness assessment, ongoing validation, and meaningful human oversight. Algorithmic risk estimates should be communicated as conditional and contextual probabilities within patient-centered counseling, ensuring that predictive tools support informed, transparent, and value-concordant fertility-preservation decisions for women facing cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.